These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32093889)

  • 61. Characterization of Human and Murine T-Cell Immunoglobulin Mucin Domain 4 (TIM-4) IgV Domain Residues Critical for Ebola Virus Entry.
    Rhein BA; Brouillette RB; Schaack GA; Chiorini JA; Maury W
    J Virol; 2016 Jul; 90(13):6097-6111. PubMed ID: 27122575
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Filovirus entry into cells - new insights.
    Miller EH; Chandran K
    Curr Opin Virol; 2012 Apr; 2(2):206-14. PubMed ID: 22445965
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The current landscape of nucleic acid tests for filovirus detection.
    Clark DJ; Tyson J; Sails AD; Krishna S; Staines HM
    J Clin Virol; 2018 Jun; 103():27-36. PubMed ID: 29625392
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The structural basis for filovirus neutralization by monoclonal antibodies.
    King LB; West BR; Schendel SL; Saphire EO
    Curr Opin Immunol; 2018 Aug; 53():196-202. PubMed ID: 29940415
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The conformational feasibility for the formation of reaching dimer in ASV and HIV integrase: a molecular dynamics study.
    Balasubramanian S; Rajagopalan M; Bojja RS; Skalka AM; Andrake MD; Ramaswamy A
    J Biomol Struct Dyn; 2017 Dec; 35(16):3469-3485. PubMed ID: 27835934
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Crystal structure of the VanR transcription factor and the role of its unique α-helix in effector recognition.
    Kwak YM; Park SC; Na HW; Kang SG; Lee GS; Ko HJ; Kim PH; Oh BC; Yoon SI
    FEBS J; 2018 Oct; 285(20):3786-3800. PubMed ID: 30095229
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Small Animal Models for Studying Filovirus Pathogenesis.
    Yamaoka S; Banadyga L; Bray M; Ebihara H
    Curr Top Microbiol Immunol; 2017; 411():195-227. PubMed ID: 28653189
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Solution structure of a double mutant of the carboxy-terminal dimerization domain of the HIV-1 capsid protein.
    Wong HC; Shin R; Krishna NR
    Biochemistry; 2008 Feb; 47(8):2289-97. PubMed ID: 18220423
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The crystal structure of KSHV ORF57 reveals dimeric active sites important for protein stability and function.
    Yuan F; Gao ZQ; Majerciak V; Bai L; Hu ML; Lin XX; Zheng ZM; Dong YH; Lan K
    PLoS Pathog; 2018 Aug; 14(8):e1007232. PubMed ID: 30096191
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ebola virus VP30 is an RNA binding protein.
    John SP; Wang T; Steffen S; Longhi S; Schmaljohn CS; Jonsson CB
    J Virol; 2007 Sep; 81(17):8967-76. PubMed ID: 17567691
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of VP30 phosphorylation in the Ebola virus replication cycle.
    Martinez MJ; Volchkova VA; Raoul H; Alazard-Dany N; Reynard O; Volchkov VE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S934-40. PubMed ID: 21987772
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Small Animal Models for Evaluating Filovirus Countermeasures.
    Banadyga L; Wong G; Qiu X
    ACS Infect Dis; 2018 May; 4(5):673-685. PubMed ID: 29457711
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RNA binding specificity of Ebola virus transcription factor VP30.
    Schlereth J; Grünweller A; Biedenkopf N; Becker S; Hartmann RK
    RNA Biol; 2016 Sep; 13(9):783-98. PubMed ID: 27315567
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human Macrophages.
    Stantchev TS; Zack-Taylor A; Mattson N; Strebel K; Broder CC; Clouse KA
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31547585
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Crystal Structure of the DNA-Binding Domain of Human Herpesvirus 6A Immediate Early Protein 2.
    Nishimura M; Wang J; Wakata A; Sakamoto K; Mori Y
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794035
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Possible leap ahead in filovirus therapeutics.
    Falzarano D; Feldmann H
    Cell Res; 2014 Jun; 24(6):647-8. PubMed ID: 24732011
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Virus and host interactions critical for filoviral RNA synthesis as therapeutic targets.
    Basler CF; Krogan NJ; Leung DW; Amarasinghe GK
    Antiviral Res; 2019 Feb; 162():90-100. PubMed ID: 30550800
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Live-Cell Imaging of Filoviruses.
    Schudt G; Dolnik O; Becker S
    Methods Mol Biol; 2017; 1628():195-202. PubMed ID: 28573621
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Binding of rabies virus polymerase cofactor to recombinant circular nucleoprotein-RNA complexes.
    Ribeiro Ede A; Leyrat C; Gérard FC; Albertini AA; Falk C; Ruigrok RW; Jamin M
    J Mol Biol; 2009 Dec; 394(3):558-75. PubMed ID: 19781554
    [TBL] [Abstract][Full Text] [Related]  

  • 80. First insights into the structural features of Ebola virus methyltransferase activities.
    Valle C; Martin B; Ferron F; Roig-Zamboni V; Desmyter A; Debart F; Vasseur JJ; Canard B; Coutard B; Decroly E
    Nucleic Acids Res; 2021 Feb; 49(3):1737-1748. PubMed ID: 33503246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.